Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…
The post New tentative approval for Watson Labs drug dienoge…
There’s no reason to assume that every branded drug will fall victim to the “patent cliff.” Actions taken before drug patent expiration can extend drug life cycles.
The post 5 Steps to Take When Your Drug Patent is About to Expire appeared first on Dru…
VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…
Annual Drug Patent Expirations for LENVIMA Lenvima is a drug marketed by Eisai Inc and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Eisai Inc drug LENVIMA appeared first on DrugPatentWatch …
Annual Drug Patent Expirations for VRAYLAR Vraylar is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Allergan Sales drug VRAYLAR appeared first on DrugPatentWa…
Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Dow Pharm and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Dow Pharm drug BRYHALI appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for MYTESI Mytesi is a drug marketed by Napo Pharms Inc and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Napo Pharms drug MYTESI appeared first on DrugPatentWatch – Mak…
Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…
The post New tentative approval for Watson Labs drug dienoge…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Lithuania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutic…
VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…